n Cardiovascular Journal of South Africa - Benefit of clopidogrel in recent myocardial infarction trials : drug trends in cardiology

Volume 16, Issue 3
  • ISSN : 1680-0745



Extracted from text ... Professor Michel Bertrand, visiting South Africa soon after the American College of Cardiology 54th Annual Con gress meeting, focused on the importance of achieving reperfusion as early as possible in the management of acute coronary syndromes. 'In my view, substantiated by recent trials, therapy of aspirin and clopidogrel (300 mg) should be started in the ambulance, preferably within 90 minutes of the event. This simple solution will soon be part of all international guidelines', Prof. Bertrand noted. The two trials announced at the ACC Congress involved 50 000 patients with ST-segment elevation myocardial in farction (STEMI). Together they showed convincing evidence ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error